WO2003052377A9 - 41 human secreted proteins - Google Patents

41 human secreted proteins Download PDF

Info

Publication number
WO2003052377A9
WO2003052377A9 PCT/US2002/035606 US0235606W WO03052377A9 WO 2003052377 A9 WO2003052377 A9 WO 2003052377A9 US 0235606 W US0235606 W US 0235606W WO 03052377 A9 WO03052377 A9 WO 03052377A9
Authority
WO
WIPO (PCT)
Prior art keywords
secreted proteins
human secreted
proteins
novel human
relates
Prior art date
Application number
PCT/US2002/035606
Other languages
French (fr)
Other versions
WO2003052377A2 (en
Inventor
Craig A. Rosen
Steven M. Ruben
Original Assignee
Human Genome Sciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences, Inc. filed Critical Human Genome Sciences, Inc.
Priority to AU2002365153A priority Critical patent/AU2002365153A1/en
Priority to EP02803305A priority patent/EP1583947A2/en
Priority to CA002478313A priority patent/CA2478313A1/en
Publication of WO2003052377A2 publication Critical patent/WO2003052377A2/en
Priority to US10/773,236 priority patent/US20050208602A1/en
Publication of WO2003052377A9 publication Critical patent/WO2003052377A9/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.
PCT/US2002/035606 2001-08-10 2002-11-06 41 human secreted proteins WO2003052377A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2002365153A AU2002365153A1 (en) 2001-11-07 2002-11-06 41 human secreted proteins
EP02803305A EP1583947A2 (en) 2001-11-07 2002-11-06 41 human secreted proteins
CA002478313A CA2478313A1 (en) 2001-11-07 2002-11-06 41 human secreted proteins
US10/773,236 US20050208602A1 (en) 2001-08-10 2004-02-09 89 human secreted proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33104601P 2001-11-07 2001-11-07
US60/331,046 2001-11-07

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/773,236 Continuation-In-Part US20050208602A1 (en) 2001-08-10 2004-02-09 89 human secreted proteins

Publications (2)

Publication Number Publication Date
WO2003052377A2 WO2003052377A2 (en) 2003-06-26
WO2003052377A9 true WO2003052377A9 (en) 2013-10-24

Family

ID=23292395

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/035606 WO2003052377A2 (en) 2001-08-10 2002-11-06 41 human secreted proteins

Country Status (4)

Country Link
EP (1) EP1583947A2 (en)
AU (1) AU2002365153A1 (en)
CA (1) CA2478313A1 (en)
WO (1) WO2003052377A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2009001928A1 (en) * 2007-06-28 2010-08-26 アスビオファーマ株式会社 Peptide having hypotensive activity
MX2015017341A (en) 2013-07-09 2016-07-06 Anexxon Inc Anti-complement factor c1q antibodies and uses thereof.
JP6951246B2 (en) 2014-11-05 2021-10-20 アネクソン，インコーポレーテッド Humanized anti-complement factor C1q antibody and its use
SG11201803703UA (en) 2015-11-24 2018-06-28 Annexon Inc Anti-complement factor c1q fab fragments and uses thereof

Also Published As

Publication number Publication date
AU2002365153A1 (en) 2003-06-30
EP1583947A2 (en) 2005-10-12
WO2003052377A2 (en) 2003-06-26
CA2478313A1 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
EP1053245A4 (en) 45 human secreted proteins
WO1998039446A3 (en) 70 human secreted proteins
WO1998039448A3 (en) 186 human secreted proteins
WO1998031800A3 (en) Human proteins
WO1998040483A3 (en) 28 human secreted proteins
WO2001032910A3 (en) 27 human secreted proteins
WO2001036432A3 (en) 18 human secreted proteins
CY1111950T1 (en) 32 HUMAN EXTRACTED PROTEINS
WO2001012776A3 (en) 18 human secreted proteins
WO1998045712A3 (en) 20 human secreted proteins
WO2001034768A3 (en) 15 human secreted proteins
WO2000017222A8 (en) 31 human secreted proteins
WO2000077026A8 (en) 49 human secreted proteins
WO2000063230A3 (en) 49 human secreted proteins
WO2001062891A3 (en) 207 human secreted proteins
EP1042342A4 (en) 53 human secreted proteins
WO2000058339A3 (en) 50 human secreted proteins
WO2000068247A3 (en) Serine proteases
WO2001012775A8 (en) 25 human secreted proteins
WO2000061624A8 (en) 48 human secreted proteins
WO2000043495A3 (en) 33 human secreted proteins
WO2003052377A9 (en) 41 human secreted proteins
WO2000061596A8 (en) 50 human secreted proteins
WO2003031586A3 (en) Acrp30-like polynucleotides, polypeptides, and antibodies
WO2002099066A3 (en) 20 human secreted proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2478313

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002803305

Country of ref document: EP

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 2002803305

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002803305

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP